Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Winston

Showing results (51-60 of 95) with videos related to

Pageof 10
Sort By:
Archives of Internal Medicine|September 1, 1982
Piperacillin plus amikacin therapy v carbenicillin plus amikacin therapy in febrile, granulocytopenic patientsD J Winston, W G Ho, L S Young, et al.
The Journal of Antimicrobial Chemotherapy|March 1, 1986
Ureidopenicillins, aztreonam, and thienamycin: efficacy as single-drug therapy of severe infections and potential as components of combined therapyD J Winston, W G Ho, R E Champlin, et al.
The American Journal of Medicine|May 1, 1986
Norfloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patientsD J Winston, W G Ho, S L Nakao, et al.
Journal of Neurosurgery|August 1, 1983
Successful treatment of spinal arachnoiditis due to coccidioidomycosis. Case reportD J Winston, T O Kurtz, J Fleischmann, et al.
British Journal of Haematology|September 1, 1987
Bone marrow transplantation in patients with leukaemia previously transfused with blood products from family membersW G Ho, R E Champlin, D J Winston, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1983
Safety and tolerance of recombinant leukocyte A interferon in bone marrow transplant recipientsD J Winston, W G Ho, R W Schroff, et al.
The American Journal of Medicine|July 25, 1988
Controlled trials of double beta-lactam therapy with cefoperazone plus piperacillin in febrile granulocytopenic patientsD J Winston, W G Ho, D A Bruckner, et al.
Transplantation|December 15, 1995
Long-term ganciclovir prophylaxis eliminates serious cytomegalovirus disease in liver transplant recipients receiving OKT3 therapy for rejectionD J Winston, D K Imagawa, C D Holt, et al.
Annals of Internal Medicine|September 1, 1987
Intravenous immunoglobulins as therapeutic agentsE R Stiehm, E Ashida, K S Kim, et al.
Archives of Internal Medicine|January 1, 1983
Coagulase-negative staphylococcal bacteremia in patients receiving immunosuppressive therapyD J Winston, D V Dudnick, M Chapin, et al.
Pageof 10

Showing results (51-60 of 95) with videos related to

Sort By:
Pageof 10
Archives of Internal Medicine|September 1, 1982
Piperacillin plus amikacin therapy v carbenicillin plus amikacin therapy in febrile, granulocytopenic patientsD J Winston, W G Ho, L S Young, et al.
The Journal of Antimicrobial Chemotherapy|March 1, 1986
Ureidopenicillins, aztreonam, and thienamycin: efficacy as single-drug therapy of severe infections and potential as components of combined therapyD J Winston, W G Ho, R E Champlin, et al.
The American Journal of Medicine|May 1, 1986
Norfloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patientsD J Winston, W G Ho, S L Nakao, et al.
Journal of Neurosurgery|August 1, 1983
Successful treatment of spinal arachnoiditis due to coccidioidomycosis. Case reportD J Winston, T O Kurtz, J Fleischmann, et al.
British Journal of Haematology|September 1, 1987
Bone marrow transplantation in patients with leukaemia previously transfused with blood products from family membersW G Ho, R E Champlin, D J Winston, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1983
Safety and tolerance of recombinant leukocyte A interferon in bone marrow transplant recipientsD J Winston, W G Ho, R W Schroff, et al.
The American Journal of Medicine|July 25, 1988
Controlled trials of double beta-lactam therapy with cefoperazone plus piperacillin in febrile granulocytopenic patientsD J Winston, W G Ho, D A Bruckner, et al.
Transplantation|December 15, 1995
Long-term ganciclovir prophylaxis eliminates serious cytomegalovirus disease in liver transplant recipients receiving OKT3 therapy for rejectionD J Winston, D K Imagawa, C D Holt, et al.
Annals of Internal Medicine|September 1, 1987
Intravenous immunoglobulins as therapeutic agentsE R Stiehm, E Ashida, K S Kim, et al.
Archives of Internal Medicine|January 1, 1983
Coagulase-negative staphylococcal bacteremia in patients receiving immunosuppressive therapyD J Winston, D V Dudnick, M Chapin, et al.
Pageof 10